Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-29

Clinical Trial Update: Combined Mirtazapine and SSRI Treatment of PTSD: A Placebo-Controlled Trial [Phase 4]

View source ↗

Summary

This Phase 4, placebo-controlled trial evaluated combining mirtazapine with an SSRI for Posttraumatic Stress Disorder. The results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mirtazapine (mirtazapine)

Snippet

Sponsor: Research Foundation for Mental Hygiene, Inc. | Conditions: Posttraumatic Stress Disorder | Phase 4 | Status: COMPLETED | Results posted: 2016-02-29